PAPER Sarasa L, Allué JA, Pesini P, González-Martínez A, Sarasa M
SEARCH RESULTS
330883 RESULTS
PAPER Perez-Gonzalez R, Pascual C, Antequera D, Bolos M, Redondo M, Perez DI, Pérez-Grijalba V, Krzyzanowska A, Sarasa M, Gil C, Ferrer I, Martinez A, Carro E
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease.
Neurobiol Aging. 2013 Sep;34(9):2133-45. Epub 2013 Apr 9 PubMed: 23582662PAPER Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G
Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data.
Alzheimers Dement. 2013 Apr 11; PubMed: 23583234PAPER Yao W, Zou HJ, Sun D, Ren SQ
Aβ induces acute depression of excitatory glutamatergic synaptic transmission through distinct phosphatase-dependent mechanisms in rat CA1 pyramidal neurons.
Brain Res. 2013 Jun 17;1515:88-97. PubMed: 23583290PAPER Zhou J, Liu J, Narayan VA, Ye J,
Modeling disease progression via multi-task learning.
Neuroimage. 2013 Sep;78:233-48. PubMed: 23583359PAPER Kitamura S, Kiuchi K, Taoka T, Hashimoto K, Ueda S, Yasuno F, Morikawa M, Kichikawa K, Kishimoto T
Longitudinal white matter changes in Alzheimer's disease: A tractography-based analysis study.
Brain Res. 2013 Jun 17;1515:12-8. PubMed: 23583480PAPER Arunkhamkaew S, Athipornchai A, Apiratikul N, Suksamrarn A, Ajavakom V
Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors.
Bioorg Med Chem Lett. 2013 May 15;23(10):2880-2. PubMed: 23583510PAPER Roberts JS, Uhlmann WR
Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues.
Prog Neurobiol. 2013 Apr 9; PubMed: 23583530PAPER Guffanti G, Torri F, Rasmussen J, Clark AP, Lakatos A, Turner JA, Fallon JH, Saykin AJ, Weiner M, , Vawter MP, Knowles JA, Potkin SG, Macciardi F
Increased CNV-Region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.
Genomics. 2013 Apr 11; PubMed: 23583670PAPER Tay WM, Huang D, Rosenberry TL, Paravastu AK
The Alzheimer's Amyloid-β(1-42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization.
J Mol Biol. 2013 Jul 24;425(14):2494-508. PubMed: 23583777PAPER Martino ME, de Villoria JG, Lacalle-Aurioles M, Olazarán J, Cruz I, Navarro E, García-Vázquez V, Carreras JL, Desco M
Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.
Ann Nucl Med. 2013 Apr 13; PubMed: 23585159PAPER Richardson C, Gard PR, Klugman A, Isaac M, Tabet N
Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
Int J Geriatr Psychiatry. 2013 Apr 14; PubMed: 23585364PAPER Wong HK, Veremeyko T, Patel N, Lemere CA, Walsh DM, Esau C, Vanderburg C, Krichevsky AM
De-repression of FOXO3a death axis by microRNA-132 and-212 causes neuronal apoptosis in Alzheimer's disease.
Hum Mol Genet. 2013 Aug 1;22(15):3077-92. PubMed: 23585551PAPER Sandgren V, Bäck M, Kvarnström I, Dahlgren A
Design and Synthesis of Hydroxyethylene-Based BACE-1 Inhibitors Incorporating Extended P1 Substituents.
Open Med Chem J. 2013;7:1-15. PubMed: 23585822PAPER Stemmer N, Strekalova E, Djogo N, Plöger F, Loers G, Lutz D, Buck F, Michalak M, Schachner M, Kleene R
Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.
PLoS One. 2013;8(4):e61299. PubMed: 23585889Current Filters
No filters selected